Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 540

1.

Benefit finding in response to BRCA1/2 testing.

Low CA, Bower JE, Kwan L, Seldon J.

Ann Behav Med. 2008 Feb;35(1):61-9. doi: 10.1007/s12160-007-9004-9. Epub 2008 Feb 15.

PMID:
18347905
2.

The trajectory of psychological impact in BRCA1/2 genetic testing: does time heal?

Beran TM, Stanton AL, Kwan L, Seldon J, Bower JE, Vodermaier A, Ganz PA.

Ann Behav Med. 2008 Oct;36(2):107-16. doi: 10.1007/s12160-008-9060-9. Epub 2008 Sep 12.

PMID:
18787910
3.

Attitudes and distress levels in women at risk to carry a BRCA1/BRCA2 gene mutation who decline genetic testing.

Lodder L, Frets PG, Trijsburg RW, Klijn JG, Seynaeve C, Tilanus MM, Bartels CC, Meijers-Heijboer EJ, Verhoog LC, Niermeijer MF.

Am J Med Genet A. 2003 Jun 15;119A(3):266-72.

PMID:
12784290
4.

Psychological and cancer-specific distress at 18 months post-testing in women with demonstrated BRCA1 mutations for hereditary breast/ovarian cancer.

Reichelt JG, Møller P, Heimdal K, Dahl AA.

Fam Cancer. 2008;7(3):245-54. doi: 10.1007/s10689-008-9182-z. Epub 2008 Jan 25.

PMID:
18219587
5.

BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention.

McInerney-Leo A, Biesecker BB, Hadley DW, Kase RG, Giambarresi TR, Johnson E, Lerman C, Struewing JP.

Am J Med Genet A. 2004 Oct 15;130A(3):221-7.

PMID:
15378542
6.

Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer.

van Dijk S, Timmermans DR, Meijers-Heijboer H, Tibben A, van Asperen CJ, Otten W.

J Clin Oncol. 2006 Aug 1;24(22):3672-7.

PMID:
16877736
7.

Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.

Di Prospero LS, Seminsky M, Honeyford J, Doan B, Franssen E, Meschino W, Chart P, Warner E.

CMAJ. 2001 Apr 3;164(7):1005-9.

8.

BRCA1/2 testing in hereditary breast and ovarian cancer families II: impact on relationships.

McInerney-Leo A, Biesecker BB, Hadley DW, Kase RG, Giambarresi TR, Johnson E, Lerman C, Struewing JP.

Am J Med Genet A. 2005 Mar 1;133A(2):165-9.

PMID:
15633195
9.

Coping with genetic testing for breast cancer susceptibility.

Dougall AL, Smith AW, Somers TJ, Posluszny DM, Rubinstein WS, Baum A.

Psychosom Med. 2009 Jan;71(1):98-105. doi: 10.1097/PSY.0b013e318190d7b4. Epub 2009 Jan 5.

PMID:
19124622
10.

Accommodating risk: responses to BRCA1/2 genetic testing of women who have had cancer.

Hallowell N, Foster C, Eeles R, Ardern-Jones A, Watson M.

Soc Sci Med. 2004 Aug;59(3):553-65.

PMID:
15144764
11.

Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients.

Schwartz MD, Lerman C, Brogan B, Peshkin BN, Isaacs C, DeMarco T, Halbert CH, Pennanen M, Finch C.

Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):1003-7.

12.

Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.

van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ, Bröcker-Vriends AH, van Asperen CJ, Sijmons RH, Seynaeve C, Van Gool AR, Klijn JG, Tibben A.

Patient Educ Couns. 2007 Jan;65(1):58-68. Epub 2006 Jul 26.

PMID:
16872788
13.

Cancer genetics knowledge and beliefs and receipt of results in Ashkenazi Jewish individuals receiving counseling for BRCA1/2 mutations.

Kelly K, Leventhal H, Marvin M, Toppmeyer D, Baran J, Schwalb M.

Cancer Control. 2004 Jul-Aug;11(4):236-44.

14.

The impact of receiving genetic test results on general and cancer-specific psychologic distress among members of an African-American kindred with a BRCA1 mutation.

Kinney AY, Bloor LE, Mandal D, Simonsen SE, Baty BJ, Holubkov R, Seggar K, Neuhausen S, Smith K.

Cancer. 2005 Dec 1;104(11):2508-16.

15.

Psychological distress and quality of life associated with genetic testing for breast cancer risk.

Smith AW, Dougall AL, Posluszny DM, Somers TJ, Rubinstein WS, Baum A.

Psychooncology. 2008 Aug;17(8):767-73.

PMID:
17992698
16.

Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing.

Lodder L, Frets PG, Trijsburg RW, Tibben A, Meijers-Heijboer EJ, Duivenvoorden HJ, Wagner A, van Der Meer CA, Devilee P, Cornelisse CJ, Niermeijer MF.

Eur J Hum Genet. 2001 Jul;9(7):492-500.

17.

Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.

Lerman C, Biesecker B, Benkendorf JL, Kerner J, Gomez-Caminero A, Hughes C, Reed MM.

J Natl Cancer Inst. 1997 Jan 15;89(2):148-57.

PMID:
8998184
18.

Psychological issues among children of hereditary breast cancer gene (BRCA1/2) testing participants.

Tercyak KP, Peshkin BN, Streisand R, Lerman C.

Psychooncology. 2001 Jul-Aug;10(4):336-46.

PMID:
11462232
19.

Posttraumatic stress associated with cancer history and BRCA1/2 genetic testing.

Hamann HA, Somers TJ, Smith AW, Inslicht SS, Baum A.

Psychosom Med. 2005 Sep-Oct;67(5):766-72.

PMID:
16204436
20.

Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program's experience.

Wagner Costalas J, Itzen M, Malick J, Babb JS, Bove B, Godwin AK, Daly MB.

Am J Med Genet C Semin Med Genet. 2003 May 15;119C(1):11-8.

PMID:
12704633

Supplemental Content

Support Center